Groups unite in call for DIR fee reform
Advocates of direct and indirect remuneration (DIR) fee reform are intensifying pressure on the White House to reverse the May rule that left the existing drug pricing system intact.
Jonathan Jacob
CVS moves ahead on health care model fix
a deal that was finalized last November — CVS Health is moving forward expeditiously to overhaul the health care delivery model. President and chief executive officer Larry Merlo and seven of his colleagues from the combined company’s management team recently laid
Tyler charts course at McKesson
A week before he succeeded John Hammergren as chief executive officer of McKesson Corp., Brian Tyler wrote on the company’s website that he was getting ready for the job of a lifetime. Tyler might have added that, in light of the serious problems that continue to plague the health care system in
Emerson Group donates to Ronald McDonald House
The Emerson Group recently donated its time and money to the Philadelphia Ronald McDonald House (PRMH) and worked together (clients, colleagues and Emerson employees) to fill “WELCOME FAMILY drawstring bags” filled with generous donations from Emerson clients that included oral care and personal ca
Sunscreen advice from top dermatologist
One trip to your corner drugstore and you’ll find an overwhelming number of sunscreens on the shelves; and every year it seems to grow.
Walgreens teams up with The Skin Cancer Foundation
Walgreens has joined The Skin Cancer Foundation on the road this year in support of its Destination: Healthy Skin Program — a national effort to educate consumers about the importance of effective sun protection for skin cancer prevention, and the importance of early detection.
Hy-Vee reopens acquired Weber & Judd stores
Hy-Vee Inc. in April reopened the 10 pharmacies it acquired in February from Weber & Judd, marking the end of that company’s 157-year history of dispensing drugs to customers in and around Rochester, Minn.
WBA buoys mental health program
Walgreens this month announced it will train some of its pharmacists and other employees in understanding risk factors and warning signs for mental health and addiction concerns as well as strategies for helping individuals in crisis and noncrisis situations.
Pharmacy closures put heart patients at risk
Research from the University of Illinois at Chicago shows that when pharmacies close, people stop taking widely used heart medications — like statins, beta-blockers and oral anticoagulants — that have known cardiovascular and survival benefits.
The prevalence of “Do It Yourself” health care
At the same time mindsets have shifted toward taking care of one’s personal health and wellness, the natural space has expanded and a variety of purported “better for you” and “free from” products have emerged in food, health, beauty, wellness and other lifestyle categories.
Bartell’s pilots delivery of Rxs
Bartell Drugs has begun delivering prescription medicines to three Seattle neighborhoods via a partnership with Nimble Pharmacy Inc., one of a growing number of companies offering delivery capabilities to independent brick-and-mortar pharmacies.
Groups decry drug price rule
Pharmacy organizations have decried the government’s refusal to reform direct and indirect remuneration (DIR) fees in its new drug pricing rule.
To see the art of retailing, look outside the United States
While retailing in the United States has hit a snag, one marked by a dearth of innovation and a scarcity of bold leadership, the state of the art elsewhere in the world is alive and well. While traditional retailers have for now run out of new ideas, the art itself is thriving. Examples abound. In
NACDS Annual Meeting was, as expected, unmissable
In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the National Association of Chain Drug Stores’ Annual Meeting, held each spring, remains the standard by which retail meetings are, or should be, judged.
A new era dawns for chain drug retailing
Like the mythical phoenix, the chain drug industry finds itself in the midst of a cycle of death and rebirth.
Generics will be a leading factor in the company’s advance
A biochemist by training, Marc Kikuchi’s experience stretches across the entire landscape of the pharmaceutical industry. He’s run the gamut — from consultant to entrepreneur, from involvement in wholesale to working with generics — and now finds himself at the helm of North America Generics at Dr.